NEOGEN:NSE-Neogen Chemicals Limited (INR)

COMMON STOCK | Specialty Chemicals | NSE

Last Closing Price

INR 1,763.60

Change

0.00 (0.00)%

Market Cap

INR 32.58B

Volume

1.26M

Avg Analyst Target

INR 1,416.67 (-19.67%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Neogen Chemicals Limited (NEOGEN) Stock Analysis:
Based on the Neogen Chemicals Limited stock forecasts from 3 analysts, the average analyst target price for Neogen Chemicals Limited is INR 1,416.67 over the next 12 months. Neogen Chemicals Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Neogen Chemicals Limited is Slightly Bearish, which is based on 5 positive signals and 7 negative signals. At the last closing, Neogen Chemicals Limited’s stock price was INR 1,763.60. Neogen Chemicals Limited’s stock price has changed by +330.00 % over the past week, +505.70 % over the past month and +166.02 % over the last year.

About

Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine deriva ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-04 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ASIANPAINT:NSE Asian Paints Limited

N/A

INR2,983.78B 91.64 55.24
PIDILITIND:NSE Pidilite Industries Limited

N/A

INR1,135.72B 83.64 55.22
BERGEPAINT:NSE Berger Paints India Limited

N/A

INR722.55B 84.07 51.87
SRF:NSE SRF Limited

N/A

INR597.79B 41.07 23.91
AARTIIND:NSE Aarti Industries Limited

N/A

INR344.31B 53.07 30.79
KANSAINER:NSE Kansai Nerolac Paints Limited

N/A

INR320.79B 60.03 34.87
ATUL:NSE Atul Ltd

N/A

INR257.71B 38.92 23.54
SOLARINDS:NSE Solar Industries India Limited

N/A

INR256.24B 73.88 41.86
CLEAN:NSE Clean Science and Technology L..

N/A

INR244.91B 147.46 80.53
LINDEINDIA:NSE Linde India Limited

N/A

INR211.10B 42.75 23.56

ETFs Containing NEOGEN

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 139.93% 82% B- 87% B+
Dividend Return 0.31% 9% F 12% F
Total Return 140.24% 82% B- 87% B+
Trailing 12 Months  
Capital Gain 166.02% 86% B 86% B
Dividend Return 0.34% 12% F 13% F
Total Return 166.36% 86% B 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 43.57% 80% B- 84% B
Dividend Return 0.04% 2% F 4% F
Total Return 43.61% 79% C+ 84% B
Risk Return Profile  
Volatility (Standard Deviation) 48.57% 60% D- 58% F
Risk Adjusted Return 89.79% 92% A- 96% A
Market Capitalization 32.58B 70% C- 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 113.14 6% F 8% F
Price/Book Ratio 17.80 8% F 4% F
Price / Cash Flow Ratio 38.99 27% F 14% F
EV/EBITDA 52.67 9% F 10% F
Management Effectiveness  
Return on Equity 19.86% 61% D- 76% C
Return on Invested Capital 13.14% 55% F 78% C+
Return on Assets 8.02% 49% F 75% C
Debt to Equity Ratio 63.43% 13% F 21% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.99 46% F 44% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.